Bone Club Webinar series

Three-Part Webinar Series

Join SIO for an intermediate-level (200) musculoskeletal (MSK) three-part webinar series. Part one will focus on the interventional treatment of malignant and metastatic bone lesions in both the axial and appendicular skeleton, covering techniques like ablation, cementation, and embolization. Part two will focus on the finer details of patient evaluation and procedural techniques for benign bone lesions, demonstrating bone grafting for UBC/ABC. Part three will address the general guidelines and physiology for the management of oncologic pain using cryoneurolysis, techniques for managing chest wall masses, and ablative options for management of aggressive pelvic disease tumors.

To get the most out of the series, we recommend registering for all three sessions.

Part 1: How I Do It — From Imaging Workup to Intervention: Metastatic/Malignant Bone Lesions

Faculty

Watch On-Demand

Part 2: How I Do It — From Imaging Workup to Intervention: Benign MSK Lesions

Wednesday, 8 October 2025 | 7–8:30 p.m. ET

Faculty

Watch On-Demand

Part 3: How I Do It — From Imaging Workup to Intervention: Cryoneurolysis for Pain

Wednesday, 11 November 2025 | 7–8:30 p.m. ET

Faculty

Register Now

Bone Club is supported by:

Medtronic Stryker Varian

HCC Webinar Series

Join SIO for a three-part webinar series on hepatocellular carcinoma (HCC) this fall. Part one will cover advances in treatment with a shift toward combination therapies and sequencing strategies to optimize patient outcomes. Part two will explore the role of immunotherapy in HCC, including combinations with locoregional therapies, mechanisms of resistance, biomarker predictions and other therapeutic targets. Part three will highlight ongoing critical trials of combination locoregional therapy and immunotherapy in the liver.

To get the most out of the series, we recommend registering for all three sessions. 

Part 1: Advancing HCC Treatment: Sequencing Strategies and Managing Combination Therapies

Faculty 

Moderator

headshot

Julius Chapiro, MD, PhD

Yale University

Faculty Panel

headshot

Richard Finn, MD

University of California Los Angeles

headshot

Nicholas Fidelman, MD

University of California San Francisco

Watch On-Demand

Part 2: Integrating Immunotherapy with Locoregional Therapies in HCC: Mechanisms, Biomarkers, and Resistance

Faculty 

Moderator

headshot

Julius Chapiro, MD, PhD

Yale University

Faculty Panel

headshot

Terrance Gade, MD, PhD

University of Pennsylvania

headshot

Sarah Manes

Global Liver Institute

headshot

Anjana Pillai, MD

University of Chicago

headshot

Michael Soulen, MD

University of Pennsylvania

Watch On-Demand

Part 3: Ongoing Critical Trials of Combination Locoregional Therapy and Immunotherapy in the Liver

Tuesday, 4 November 2025 | 7 – 8:30 p.m. ET

 

This webinar is sponsored by:

Boston Scientific

Faculty

Moderator

headshot

Zach Berman, MD

UC San Diego

Faculty Panel

headshot

Adam Burgoyne, MD, PhD

UC San Diego

headshot

Kirema Garcia-Reyes, MD

Mount Sinai

headshot

Christopher Malone, MD

Washington University

Register Now

This webinar series is sponsored by:

AstraZeneca

Meet The Data Podcast

Conversations with Leading Experts on HCC and Immunotherapy

SIO is launching a 4-part podcast series featuring discussions on pivotal trials that established immunotherapy’s role in advanced HCC. Supported by an educational grant from AstraZeneca.

HCC Focus

Landmark trials in hepatocellular carcinoma

Immunotherapy

Cutting-edge treatments

Expert Insights

Listen on-demand

Episode One — Moderation and Perspectives in HCC

Lead Moderator Edward Kim, MD (Mount Sinai) is joined by Cynthia De la Garza, MD (Mayo Clinic), Linling Du, MD (Ochsner Health System), and Chris Malone, MD (Washington University in St. Louis) to share insights on treatment approaches and decision-making.

Listen Now

Episode Two — Global Advances in HCC Treatment

Experts Stephen Chan, MD (Chinese University of Hong Kong) and Riad Salem, MD (Northwestern Medicine) discuss the latest advancements in HCC management and evolving international perspectives.

Listen Now

Episode Three — Translating Clinical Trials into Practice

William Rilling, MD (Medical College of Wisconsin), Parissa Tabrizian, MD (Mount Sinai Health System), and Beau Toskich, MD (Mayo Clinic) highlight how pivotal HCC trial results are being integrated into real-world practice.

Listen Now

Episode Four — Future Directions in IO and Immunotherapy

Moderators Elena Violari, MD (Loyola University Chicago) and Greg Pommier (Johns Hopkins Medicine) are joined by Gentry King, MD (University of Washington) and Isabel Newton, MD (UC San Diego) to explore future opportunities in combining IO with immunotherapy.

Listen Now

CCF Webinar: Navigating Cholangiocarcinoma - A Patient's Journey with Interventional Oncology

SIO is proud to partner with the Cholangiocarcinoma Foundation for a compelling webinar featuring renowned interventional oncologists Christos Georgiades, MD, PhD, and Sarah White, MD, MS, FSIR, and cholangiocarcinoma patient, Lynn Lazzaro. Together, they explore how interventional oncology (IO) treatments, combined with a multidisciplinary team (MDT) approach, played a pivotal role in Lynn’s care. Discover the innovative techniques and compassionate care that have made a difference in Lynn's life and learn how interventional oncology can offer hope and effective solutions for complex cancer cases. 

Faculty

David Hirschl

Christos Georgiades, MD, PhD

Johns Hopkins Medicine

Willian Moore, MD

Lynn Statz Lazzaro, CPA, CFP, MST

Willian Moore, MD

Sarah White, MD, MS, FSIR, FCIRSE

Medical College of Wisconsin

Watch On-Demand

This Webinar is in partnership with the Cholangiocarcinoma Foundation